Detalhe da pesquisa
1.
Cytoplasmic synthesis of endogenous Alu complementary DNA via reverse transcription and implications in age-related macular degeneration.
Proc Natl Acad Sci U S A
; 118(6)2021 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33526699
2.
Medicare Spending on Drugs With Accelerated Approval.
Ann Intern Med
; 175(7): 938-944, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35605235
3.
Translating Research into Health Policy: The Citizen Petition Experience with the Food and Drug Administration.
Cancer Treat Res
; 184: 61-73, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36449188
4.
Investigating Severe Adverse Reactions: Examples of the ANTICIPATE Methodology at Work.
Cancer Treat Res
; 184: 129-140, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36449193
5.
Moderna, Pfizer-BioNTech, and Johnson & Johnson/Janssen Post-Covid Vaccine Hematological Adverse Events Including Cerebral Venous Sinus Thrombosis (CVST), Thrombotic Thrombocytopenia (VITT), Blood Clots, Increased Vaginal/Menstrual Bleeding and/or Miscarriage, Stillbirth Delivery, or Premature Birth.
Cancer Treat Res
; 184: 151-160, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36449195
6.
Policing of Drug Safety Information Dissemination Under the False Claims Act.
Cancer Treat Res
; 184: 53-59, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36449187
7.
Rituximab-Associated Progressive Multifocal Leukoencephalopathy: A Twenty-Year Update.
Cancer Treat Res
; 184: 103-111, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36449191
8.
Fluoroquinolone-Associated Disability and Other Fluoroquinolone-Associated Serious Adverse Events: Unexpected Toxicities Have Emerged in Recent Years.
Cancer Treat Res
; 184: 1-39, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36449185
9.
Biosimilar Epoetin in the United States: A View from the Southern Network on Adverse Reactions.
Cancer Treat Res
; 184: 41-51, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36449186
10.
Was There Something Rotten in Denmark: Nephrogenic System Fibrosis Cases Occurring in Copenhagen.
Cancer Treat Res
; 184: 87-102, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36449190
11.
Systemic Barriers and Potential Concerns from Reporting Serious Adverse Drug Reactions.
Cancer Treat Res
; 184: 75-85, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36449189
12.
Consequences to Patients, Clinicians, and Manufacturers When Very Serious Adverse Drug Reactions Are Identified (1997-2019): A Qualitative Analysis from the Southern Network on Adverse Reactions (SONAR).
Cancer Treat Res
; 184: 141-149, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36449194
13.
Maximum Accuracy Machine Learning Statistical Analysis-A Novel Approach.
Cancer Treat Res
; 184: 113-127, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36449192
14.
The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions.
Oncologist
; 26(8): e1418-e1426, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33586299
15.
Do radiation oncologists and urologists endorse decision aids for active surveillance of low-risk prostate cancer: Results from a national survey.
Eur J Cancer Care (Engl)
; 30(1): e13301, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33112008
16.
A New Criterion for Fluoroquinolone-Associated Disability Diagnosis: Functional Gastrointestinal Disorders.
Medicina (Kaunas)
; 57(12)2021 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34946316
17.
Improving oncology biosimilar launches in the EU, the USA, and Japan: an updated Policy Review from the Southern Network on Adverse Reactions.
Lancet Oncol
; 21(12): e575-e588, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33271114
18.
End of an era for erythropoiesis-stimulating agents in oncology.
Int J Cancer
; 146(10): 2829-2835, 2020 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32037527
19.
Patient- and area-level predictors of prostate cancer among South Carolina veterans: a spatial analysis.
Cancer Causes Control
; 31(3): 209-220, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31975155
20.
Regulatory and Clinical Experiences with Biosimilar Filgrastim in the U.S., the European Union, Japan, and Canada.
Oncologist
; 24(4): 537-548, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30842244